Curexa Pharmacy
Curexa Pharmacy is a US-based 503A compounding pharmacy founded in 2003 that uses API-connected technology to dispense customized medications nationwide for telemedicine providers, medical providers, veterinarians, manufacturers, and clinical research organizations.
- Company typePrivate
- Founded2003
- HeadquartersEgg Harbor Township, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Curexa Pharmacy does
Curexa Pharmacy (legal entity EHT Pharmacy LLC) is a US-based, family-founded 503A compounding pharmacy operating since 2003 from Egg Harbor Township, New Jersey, with additional sites in Galloway, New Jersey and Gilbert, Arizona. The company compounds patient-specific customized medications — including suppositories, topical formulations, troches, creams and ointments, and capsules — often formulated to exclude problem-causing excipients such as dyes, sugar, lactose, alcohol, gluten, or preservatives, and complements compounding with traditional retail dispensing, manufacturer packaging and labeling services, and collaborative research and development for clinical formulations. Its technology foundation is an API-connected platform that integrates electronically with partner systems for prescription management and fulfillment, supporting nationwide shipping across all 50 US states alongside local pick-up and delivery.
The business model is B2B and transaction-fee based: Curexa generates revenue per compounded prescription, per dispensed prescription, and per packaging/labeling engagement, with pricing quoted per formulation rather than published. Its customer base is segmented across five verticals — telemedicine providers (positioned as the primary segment), medical providers, veterinary providers, pharmaceutical manufacturers, and clinical research organizations — served through consultative partnership sales, API integration, and accreditation-driven trust signals (503A designation, PCAB Accreditation, URAC Specialty Pharmacy Accreditation, and LegitScript Certification).
Since December 2021, the company has operated under private equity sponsorship led by Pouschine Cook Capital Management (with ORIX Capital Solutions and Hexagon as co-investors and First Horizon Bank as senior lender); co-founder Mark Taylor remains President and CEO, John Pouschine serves as Chairman, and recent senior additions include former FDA Principal Deputy Commissioner Rachel Sherman on the Board (March 2023) and Robert Cimorelli as SVP of Regulatory and Strategic Operations (February 2024). A January 2026 strategic partnership and licensing agreement with Pete Pharma extends the model from contract compounding toward proprietary, co-developed compounded products.
Curexa Pharmacy firmographics
Firmographics- Name
- Curexa Pharmacy
- Legal name
- EHT Pharmacy LLC
- Website
- https://curexa.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Curexa Pharmacy is a US-based 503A compounding pharmacy founded in 2003 that uses API-connected technology to dispense customized medications nationwide for telemedicine providers, medical providers, veterinarians, manufacturers, and clinical research organizations.
- Ownership category
- akta.pro rank
Curexa Pharmacy industry classification
Industry- Product category
- Specialty Pharmacy Services
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Compounding Pharmacies (Sterile/Non-Sterile) (HLAFALAE)
- akta.pro secondary industry
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)
Keywords
Where Curexa Pharmacy is headquartered
LocationHeadquarters
- HQ city
- Egg Harbor Township
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Curexa Pharmacy business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Compounding Pharmacy Services: Revenue generated from customized pharmaceutical compounding services for patients whose prescriptions are not commercially available. Services include various dosage forms such as suppositories, topical formulations, troches, creams, ointments, and capsules. The company serves telemedicine providers, medical providers, veterinary providers, manufacturers, and clinical research organizations nationwide.
- Traditional Dispensary Services: Traditional prescription dispensing services offering common pharmaceutical medications for both humans and pets with multiple shipping options. Includes retail, specialty, and compounding pharmacy services with local pick-up, local delivery, and nationwide shipping.
- Packaging and Labeling Services: Pharmaceutical packaging and labeling services for manufacturers including inventory management and administrative support. API connectivity and seamless integration into clients' systems ensure reliability and responsiveness.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Custom pharmaceutical compounding services with pricing based on specific formulation requirements and partnership arrangements |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Curexa Pharmacy product offering
Product offeringCore offering
Curexa Pharmacy is an API-connected 503A compounding pharmacy that produces customized pharmaceutical medications not commercially available, including multiple dosage forms such as suppositories, topicals, troches, creams, ointments, and capsules. The company also provides traditional prescription dispensary services, packaging and labeling for manufacturers, and collaborative research and development for clinical organizations. Services are delivered to telemedicine providers, medical providers, veterinary providers, manufacturers, and clinical research organizations across all 50 U.S. states.
Product overview
Curexa Pharmacy is an independent, family-owned pharmacy founded in 2003 offering a unified portfolio of pharmaceutical services centered on 503A compounding pharmacy capabilities. The core offering combines pharmaceutical compounding services (suppositories, topical formulations, troches, creams/ointments, capsules) with traditional dispensary services, research and development, and packaging/labeling solutions. Services are delivered to telemedicine providers, medical providers, veterinary providers, manufacturers, and clinical research organizations nationwide through API-connected technology infrastructure.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Compounding Services Customized medication compounding creating prescriptions not commercially available, with 503A designation allowing medications free of problem-causing excipients such as dyes, sugar, lactose, alcohol, gluten, or preservatives. Serves telemedicine, medical, and veterinary providers, manufacturers, and clinical research organizations nationwide.
- Traditional Dispensary Services Retail pharmacy dispensing services for common pharmaceutical medications for humans and pets, with multiple shipping options including local pick-up, local delivery, and nationwide shipping with discreet packaging.
- Research and Development Services
Companies that use Curexa Pharmacy
Customer profileSegments6 records
Ideal customer profiles5 records
Curexa Pharmacy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Curexa Pharmacy partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Pete PharmacoreStrategic partnership designed to support Curexa's growth through access to Pete Pharma's intellectual property, formulation expertise, and scalable product development infrastructure. Includes a definitive licensing agreement under which Pete Pharma will support Curexa in the research, development, and commercialization of proprietary compounded products.
- McDermott Will & Emery LLPminorLegal advisor to the buyer group in the Curexa investment transaction led by Pouschine Cook Capital.
- Covington AssociatesminorServed as exclusive financial advisor to Curexa in the Pouschine Cook investment transaction.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Curexa Pharmacy competitors and assessment
Company assessmentEmerging players
- KlaraScript Pharmacy: Tech-forward compounding pharmacy offering API and digital tools for telehealth providers. Comparable to Curexa's API-first positioning, though smaller in scale and more narrowly focused on telehealth integrations.
Direct peers
- Wedgewood Pharmacy: Specialty compounding pharmacy with one of the largest veterinary compounding practices in the U.S. Directly comparable to Curexa's veterinary compounding segment and broader 503A compounding model, with PE backing from Welsh Carson.
- Empower Pharmacy: One of the largest 503A and 503B compounding pharmacies in the U.S., serving telehealth providers, medical practices, and patients nationwide. Directly comparable to Curexa in regulatory designation, telehealth-partner GTM, and national-scale 503A compounding focus.
- US Compounding Pharmacy: 503A compounding pharmacy offering customized preparations for humans and animals. Directly comparable to Curexa's core 503A compounding services and nationwide shipping model for provider-partnered prescriptions.
- Boothwyn Pharmacy: 503A compounding pharmacy serving physicians and patients with customized medications. Comparable to Curexa as a Pennsylvania-based 503A compounding peer serving medical providers; Robert Cimorelli (Curexa's SVP Regulatory) previously worked here.
- Precision Compounding Pharmacy: 503A compounding pharmacy serving medical providers and patients with customized formulations across hormone therapy, dermatology, and other specialties. Comparable to Curexa's compounding dosage forms (topicals, capsules, troches) and provider partnership model.
- Diamondback Drugs: Veterinary-focused compounding pharmacy serving veterinarians with customized formulations. Directly comparable to Curexa's veterinary compounding service line and its emphasis on flavored and transdermal preparations for pets and exotics.
Broad incumbents
- BioPlus Specialty Pharmacy: Specialty pharmacy providing compounding and specialty therapies for chronic and complex conditions. Comparable as an accredited specialty pharmacy with national provider relationships, though broader in therapeutic scope than Curexa.
- Pentec Health: Specialty pharmacy and compounding services provider focused on complex patient populations including intrathecal and parenteral nutrition. Comparable to Curexa as a specialized pharmacy services provider; Robert Cimorelli (Curexa SVP Regulatory) previously held a role here.
- Avella Specialty Pharmacy: URAC-accredited specialty pharmacy with broad therapeutic and compounding capabilities, now part of Optum Specialty Pharmacy. Comparable to Curexa as a nationally accredited specialty/compounding pharmacy serving provider networks.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Curexa Pharmacy social profiles
Digital presenceCurexa Pharmacy compliance and trust
Trust signalCompliance5 records
Curexa Pharmacy financial estimates
Financial estimateRevenue estimate
Valuation estimate
Curexa Pharmacy leadership team
Management profileNumber of profiles
Profiles7 records
Curexa Pharmacy funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Curexa Pharmacy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Curexa Pharmacy
What does Curexa Pharmacy do?
Curexa Pharmacy is an API-connected 503A compounding pharmacy that produces customized pharmaceutical medications not commercially available, including multiple dosage forms such as suppositories, topicals, troches, creams, ointments, and capsules. The company also provides traditional prescription dispensary services, packaging and labeling for manufacturers, and collaborative research and development for clinical organizations. Services are delivered to telemedicine providers, medical providers, veterinary providers, manufacturers, and clinical research organizations across all 50 U.S. states.
Is Curexa Pharmacy a public or private company?
Curexa Pharmacy is a private company. It is classified as private equity controlled and is currently operating.
When was Curexa Pharmacy founded?
Curexa Pharmacy was founded in 2003. It employs 101 to 250 people.
Where is Curexa Pharmacy based?
Curexa Pharmacy is headquartered in Egg Harbor Township, United States, in the North America region.
How does Curexa Pharmacy make money?
Three revenue lines are on record. Compounding Pharmacy Services are the primary driver. The others are traditional Dispensary Services and packaging and Labeling Services.
Who are Curexa Pharmacy's main competitors?
KlaraScript Pharmacy is listed as an emerging player. Direct peers are Wedgewood Pharmacy, Empower Pharmacy, US Compounding Pharmacy, Boothwyn Pharmacy, Precision Compounding Pharmacy and Diamondback Drugs. Broad incumbents are BioPlus Specialty Pharmacy, Pentec Health and Avella Specialty Pharmacy.
Does Curexa Pharmacy have an API?
Yes. Curexa offers API capabilities that enable seamless electronic integration into clients' systems and existing processes. The API connectivity allows partners to connect directly with Curexa's systems for order management, prescription fulfillment, and pharmacy operations. Curexa describes itself as an 'API-connected 503A compounding pharmacy' serving telemedicine providers and partners nationwide.
What industry is Curexa Pharmacy in?
Curexa Pharmacy's product category is Specialty Pharmacy Services. Its primary akta.pro industry code is HLAFALAE, Compounding Pharmacies (Sterile/Non-Sterile), with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 325412 and its SIC code is 2834.